Pelthos Therapeutics Inc.
DURHAM, NC · Founded 2021 · CIK 0001919246 · Biotech · Public
Therapeutic pharmaceutical products for patients with unmet medical needs
pelthos.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $69M
- 4 Form D · Nov 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $30,000,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $50,100,000 | |
| Private capital raised | Form D · SEC | $18,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1261 | CODOMAX INC. | — | — |
| 1262 | Young Biopharma, LLC | — | — |
| 1263 | Proteovant Therapeutics | — | — |
| 1264 | Pelthos Therapeutics Inc. | — | $69M |
| 1265 | Mediar Therapeutics | — | $75M |
| 1266 | MOLECULAR TECHNOLOGIES LABORATORIES LLC | — | — |
| 1267 | MARTINGALE LABS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard BaxterDirector
- Todd DavisDirector
- Ezra FriedbergDirector
- Peter GreenleafDirector
- Francis KnuettelExecutive Officer
- Francis Knuettel IIExecutive Officer
- Eric LangExecutive Officer
- Richard MalamutDirector
- Matthew PaulsDirector
- Scott PleshaDirector · Executive Officer
- Sai RangaraoExecutive Officer
- Chia-Lin SimmonsDirector
Patents
- Injectable Formulations in a Method for Treating Painapplication
- Ophthalmic Formulationsapplication
- Pediculicidal Compositionapplication
- Ophthalmic Formulationsapplication
- Ophthalmic Formulationsapplication
- Injectable Formulationsapplication
- Ophthalmic Formulationsapplication
- Injectable Formulationsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.